News Posts List
+ News Categories + Corporate Categories Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
04/30/2012
Erlotinib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.
Why singer and actress Olivia Newton-John is hopelessly devoted to a healthy diet
04/30/2012
Her daughterÂ’s best friend died when she was just five years old of a kidney cancer that is believed to be caused by environmental factors, and Newton-John has been organic ever since.
'I've had to kiss a lot of frogs to find my prince!'
04/30/2012
Yet within a fortnight, her father Marty died following a short battle with kidney cancer.
AVEO set to move from start-up to producer
04/28/2012
A decade after AVEO Pharmaceuticals was founded...
CDMRP programs help ensure funding for medical research
04/28/2012
The medical research programs within the CDMRP directly impact the health and lives of the U.S. military, their families and the public. Call your Congressman to urge support today!
Role of immunohistochemistry in diagnosing renal neoplasms
04/28/2012
With the refinement of molecular and histologic classifications of renal neoplasms and the availability of more-effective molecular targeted therapy for specific renal neoplasms, immunohistochemical techniques will play an increasingly important role in the diagnosis of renal neoplasm. During the past few decades, many markers have been evaluated for their role in the diagnosis, prognosis, and prediction of treatment for renal neoplasms. The number of useful markers in our routine practice continues to increase.
Kidney Cancer Patients Fare Better With Tumor Removal Only
04/28/2012
Kidney cancer patients who have only the tumor removed, not the entire kidney, have higher survival rates, a new study finds.
Renal cell carcinoma metastasis to the ciliary body responds to proton beam radiotherapy
04/28/2012
We report an unexpected presentation of metastatic renal cell carcinoma (RCC) to the ciliary body and an interesting response to proton beam radiotherapy.
NIH Research Funding Faces An Unprecedented Threat
04/28/2012
Here's why your support of the American Kidney Cancer Alliance (AKCA.US) is more important than ever before: we must join together to help better explain and illustrate the value of cancer research and biomedical science to the economic health and well-being of the nation (as AACR asserts).
Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms
04/28/2012
This article will review the recent advances that form the current framework of therapy for RCC, as well as summarize key areas of progress and innovation in the evolving treatment paradigms for this disease.